Febit granted patent for microfluidic extraction method

Febit’s new patented method is known as hybselect, targeted sequencing or sequence capture. Using this technique, researchers are able to isolate genes or genomic regions of interest from a complex DNA sample prior to sequencing.

Febit’s microfluidic microarray-based method forms the basis of a novel technology that enables the expanded use of next-generation sequencers in genomic research. Further investigation of the human genome by resequencing will particularly benefit from the new method: febit uses its microfluidic biochip system for sequence-based selective isolation of nucleic acids from genomic samples.